innate

1α,25(OH)₂D₃ reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells
Peng Li, Xinhai Zhu, Guangchao Cao, Ruan Wu, Ke Li, Wenhui Yuan, Biyun Chen, Guodong Sun, Xichun Xia, Hua Zhang, Xiao Wang, Zhinan Yin, Ligong Lu, Yunfei Gao

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003477; DOI: 10.1136/jitc-2021-003477
Intermediate monocytes induced by IFN-γ inhibit cancer metastasis by promoting NK cell activation through FOXO1 and interleukin-27
Rikang Wang, Weili Bao, Mouli Pal, Yunfeng Liu, Karina Yazdanbakhsh, Hui Zhong

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003539; DOI: 10.1136/jitc-2021-003539
CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor
Serena Zilio, Silvio Bicciato, Donald Weed, Paolo Serafini

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003131; DOI: 10.1136/jitc-2021-003131
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J Gradishar, Hope S Rugo, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003171; DOI: 10.1136/jitc-2021-003171
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
Amani Makkouk, Xue (Cher) Yang, Taylor Barca, Anthony Lucas, Mustafa Turkoz, Jonathan T S Wong, Kevin P Nishimoto, Mary M Brodey, Maryam Tabrizizad, Smitha R Y Gundurao, Lu Bai, Arun Bhat, Zili An, Stewart Abbot, Daulet Satpayev, Blake T Aftab, Marissa Herrman

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003441; DOI: 10.1136/jitc-2021-003441
Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progression
Laura A Mittmann, Florian Haring, Johanna B Schaubächer, Roman Hennel, Bojan Smiljanov, Gabriele Zuchtriegel, Martin Canis, Olivier Gires, Fritz Krombach, Lesca Holdt, Sven Brandau, Thomas Vogl, Kirsten Lauber, Bernd Uhl, Christoph A Reichel

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003495; DOI: 10.1136/jitc-2021-003495
Activated but impaired IFN-γ production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma
Wenyong Huang, Dongmei Ye, Wenjing He, Xiaoshun He, Xiaomin Shi, Yifang Gao

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003685; DOI: 10.1136/jitc-2021-003685
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
Shih-Hsun Chen, Pawel K Dominik, Jessica Stanfield, Sheng Ding, Wenjing Yang, Nadia Kurd, Ryan Llewellyn, Jonathan Heyen, Carole Wang, Zea Melton, Thomas Van Blarcom, Kevin C Lindquist, Javier Chaparro-Riggers, Shahram Salek-Ardakani

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003464; DOI: 10.1136/jitc-2021-003464
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Clément Anfray, Francesco Mainini, Elisabeth Digifico, Akihiro Maeda, Marina Sironi, Marco Erreni, Achille Anselmo, Aldo Ummarino, Sara Gandoy, Francisco Expósito, Miriam Redrado, Diego Serrano, Alfonso Calvo, Marvin Martens, Susana Bravo, Alberto Mantovani, Paola Allavena, Fernando Torres Andón

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002408; DOI: 10.1136/jitc-2021-002408
CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
Shifaa M. Abdin, Daniela Paasch, Michael Morgan, Nico Lachmann

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002741; DOI: 10.1136/jitc-2021-002741

Main menu

innate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

innate

Pages